Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2924 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2019-01-08 | 2020-04-02 | 71550 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2019-01-08 | 2020-03-19 | 71553 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2020-05-21 | 2020-06-04 | 115553 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2020-08-13 | 2021-03-25 | 122208 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2020-10-01 | 2021-04-29 | 125491 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2021-05-20 | 2021-12-17 | 139731 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176848 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2022-12-01 | 2024-01-11 | 176851 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2023-06-19 | 2023-07-05 | 195429 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2023-11-03 | 2024-04-25 | 209111 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2024-02-29 | 2024-09-19 | 220983 |
| TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2024-07-04 | 2025-01-23 | 232214 |
| TEVA-FOSINOPRIL | 10MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19955 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19960 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120881 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197539 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2024-03-18 | 2024-04-05 | 222563 |
| TEVA-FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2020-01-24 | 2020-02-26 | 104353 |
| TEVA-FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2020-04-02 | 2020-05-01 | 110691 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2017-04-03 | 2017-05-23 | 5197 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |